Infergen
Active Ingredient(s): Interferon Alfacon-1FDA Approved: * October 6, 1997
Pharm Company: * INTERMUNE PHARMS
Category: Hepatitis
* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".
Infergen Overview
Interferon alfacon-1 is a recombinant synthetic type I interferon used for the treatment of hairy cell leukemia, malignant melanoma and AIDS-related Kaposi's sarcoma.[1] References ^ DrugBank DB00069 .mw-parser-output .navbar{display:inline;font-size:88%;font-weight:normal}.mw-parser-output .navbar-collapse{float:left;text-align:left}.mw-parser-output .navbar-boxtext{word-spacing:0}.mw-parser-output .navbar ul{display:inline-block;white-space:nowrap;line-height:inherit}...
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Interferon_alfacon-1
Recent Infergen Forums:
Be the first to start a discussion about this drug.Possible Dosages for this and Related Drugs:
Interferon Alfacon-1
- Injection: 15mcg/0.5ml, 30mcg/ml, 9mcg/0.3ml
- Vial: 30ug/ml
NDC Database Records for Infergen: (2 results)
Sorted by National Drug Code- 66435-201 Infergen .03 mg/ml Subcutaneous Injection by Kadmon Pharmaceuticals, LLC
- 66435-202 Infergen .03 mg/ml Subcutaneous Injection by Kadmon Pharmaceuticals, LLC